Celentyx Ltd

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Celentyx Ltd

Feb 2, 2025, 19:47 | Science

TNBC modifies the systemic immune landscape and alters neutrophil functionality

John Gordon, VP Scientific Affairs at Celentyx Ltd, shared an article by Noor A. M.…

Nov 6, 2024, 12:01 | Insight

John Gordon: Dual “ON/OFF”-switch CARs offer a safer CAR T cell therapy

John Gordon, Vice president of Scientific Affairs at Celentyx Ltd, shared a post on LinkedIn: “Dual ‘ON/OFF’-switch CARs…

All: 2 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023